Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.

Nineteen new derivatives based on the structure of marine natural product tasiamide B were designed, synthesized, and evaluated for their inhibitory activity against BACE1, a potential therapeutic target for Alzheimer's disease. The hydrophobic substituents Val at P₃ position, Leu at P₁' position, Ala at P₂' position, and Phe at P₃' position were found to significantly affect the inhibition. Free carboxylic acid at C-terminus was also found to be important to the activity. In addition, the structure-activity relationships (SARs) were supported by molecular docking simulation.

[1]  Daniel Oehlrich,et al.  The evolution of amidine-based brain penetrant BACE1 inhibitors. , 2014, Bioorganic & medicinal chemistry letters.

[2]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[3]  Y. Kiso,et al.  Small-sized BACE1 inhibitors , 2006 .

[4]  Alison R. Gregro,et al.  Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). , 2004, Journal of medicinal chemistry.

[5]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[6]  Dongwoo Shin,et al.  Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase). , 2000, Journal of the American Chemical Society.

[7]  Hannes A. Braun,et al.  Modulators and Inhibitors of γ- and β-Secretases , 2006, Neurodegenerative Diseases.

[8]  S. Martín-Aragón,et al.  Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils. , 2011, Bioorganic & medicinal chemistry letters.

[9]  Yechun Xu,et al.  Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases. , 2012, Journal of medicinal chemistry.

[10]  Joseph B. Moon,et al.  Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase. , 2007, Journal of medicinal chemistry.

[11]  Kenichiro Fujiwara,et al.  Conformational restriction approach to β-secretase (BACE1) inhibitors III: effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations. , 2013, Bioorganic & medicinal chemistry.

[12]  Arun K. Ghosh,et al.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. , 2014, Chemical Society reviews.

[13]  J. Macor,et al.  P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid β Reduction by β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[14]  Arun K. Ghosh,et al.  Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase) , 2001 .

[15]  L Hong,et al.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. , 2000, Science.

[16]  Joseph B. Moon,et al.  Design and Synthesis of Hydroxyethylene-Based Peptidomimetic Inhibitors of Human β-Secretase , 2004 .

[17]  Bruno Martoglio,et al.  Aspartic proteases in drug discovery. , 2007, Current pharmaceutical design.

[18]  Yechun Xu,et al.  Discovery of pyrazole as C-terminus of selective BACE1 inhibitors. , 2013, European journal of medicinal chemistry.

[19]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[20]  P. Williams,et al.  A simple microscale method for determining the relative stereochemistry of statine units. , 2008, The Journal of organic chemistry.

[21]  Conformational restriction approach to BACE1 inhibitors II: SAR study of the isocytosine derivatives fixed with a cis-cyclopropane ring. , 2013, Bioorganic & medicinal chemistry letters.

[22]  J. Tao,et al.  An Improved Enantiospecific Synthesis of Statine and Statine Analogs via 4-(N,N-Dibenzylamino)-3-keto Esters. , 1997, The Journal of organic chemistry.

[23]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[24]  Y. Kiso,et al.  Advances in the identification of β-secretase inhibitors , 2013, Expert opinion on drug discovery.

[25]  Hannes A. Braun,et al.  Inhibitors and Modulators of β- and γ-Secretase , 2006 .

[26]  J. Tang,et al.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Kiso,et al.  Recent progress in the drug discovery of non-peptidic BACE1 inhibitors , 2009, Expert opinion on drug discovery.

[28]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[29]  J. Tao,et al.  A Stereocontrolled, Convergent Synthesis of Hydroxyethylene Dipeptide Isosteres , 1997 .

[30]  E. Novellino,et al.  A stereoselective approach to peptidomimetic BACE1 inhibitors. , 2013, European journal of medicinal chemistry.